Please login to the form below

Not currently logged in
Email:
Password:

inVentiv acquires Catalina Health

Expands patient adherence business
Inventiv Logo

inVentiv has expanded its efforts in adherence with the purchase of Catalina Health.

Catalina Health – formerly a subsidy of Catalina Marketing – will be merged into inVentiv's existing Adheris division, providing adherence programmes such as refill reminders and disease education.

The new company benefits from a network of more than 40 pharmacy partners, involving 30,000 pharmacies responsible for 65 per cent of all retail prescriptions. Adheris is also building its physician office and pharmacy networks, it said.

The acquisition allows Adheris to offer clients a single vendor for multiple services. This co-ordinated approach will reach individual patients “across multiple touch points with customised messages predictive analytics” said Mark Dmytruk, president, inVentiv Health Patient Outcomes.

“It improves adherence in ways other organisations simply cannot match,” he added.  

Combining Catalina Health's and Adheris' expertise in predictive analytics will allow the new company to offer stronger and more effective messaging based on a more robust understanding of consumer preferences and needs, it believes.

"Over the past year, we've seen growing client demand for co-ordinated patient messaging and an increased focus on patient-centric outcome strategies," said Dmytruk.  "The acquisition improves our ability to deliver exactly what our clients need."

Renee Selman, president of Catalina Health, will lead the combined business.  Prior to joining Catalina Health, Selman served in various leadership positions with Johnson & Johnson, including a stint as worldwide president of the subsidiary Ethicon Women's health and urology business.

Jim Rotsart will move from general manager, executive VP of Adheris to become executive VP of inVentiv Health Patient Outcomes.


5th November 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics